An open-label exploratory study evaluating the efficacy and safety of ingenol mebutate gel 0.05% for the treatment of verruca vulgaris


10 aprile 2018 - 16:37Ricerca


Current therapies for common warts (verruca vulgaris) often require months of treatment and focus on destruction, removal of callus, or stimulation of a local immune response. Topical use of ingenol mebutate gel, 0.05%, indicated for the treatment of actinic keratosis, induces necrosis and an inflammatory reaction. A recent case study series provided evidence for the efficacy of ingenol mebutate against anogenital warts.

Neal D. Bhatia, MD

JAAD March 2018 Volume 78, Issue 3, Pages 595-596

Inserito da segreteria SIDeMaST

Lascia un commento sul sito e rispondi all'autore

I commenti sono soggetti a moderazione: non saranno pubblicati immediatamente ma dovranno essere approvati dalla segreteria.

Eventi SIDeMaST

Stato iscrizione